MLN9708

Millennium starts Phase 3 trial for amyloidosis
Mass High Tech, MA
Sat, 10/20/12 - 11:46 am
MLN9708
Millennium
amyloidosis
Millennium begins phase III trial evaluating MLN9708 in patients with relapsed and/or refractory multiple myeloma
Pharmabiz
Sat, 06/30/12 - 04:35 pm
MLN9708
Multiple Myeloma
Millennium